Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol

Advances in Experimental Medicine and Biology

Volumn 414, Issue , 1997, Pages 133-146

  Rekha, Ganaganur K ^a   Sladek, Norman E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; GOSSYPOL; MAFOSFAMIDE; OXAZAPHOSPHORINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL KILLING; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ALDEHYDE DEHYDROGENASE; ANTINEOPLASTIC AGENTS, ALKYLATING; BREAST NEOPLASMS; CATECHOLS; CELL SURVIVAL; CYCLOPHOSPHAMIDE; ENZYME INDUCTION; FEMALE; GASTRIC MUCOSA; GOSSYPOL; HUMANS; KINETICS; PHOSPHORAMIDE MUSTARDS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0030949770     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (59)

1. Band, V., Hoffer, A.P., Band, H., Rhinehardt, A.E., Knapp, R.C., Matlin, S.A. and Anderson, D.J.: Antiproliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines. Gynecol. Oncol. 32 (1989) 273-277.
2. Benz, C.C., Keniry, M.A., Ford, J.M., Townsend, A.J., Cox, F.W., Palayoor, S., Matlin, S.A., Hait, W.N. and Cowan, K.H.: Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Mol. Pharmacol. 37 (1990) 840-847.
3. Bunting, K.D. and Townsend, A.J.: Protection by transfected rat or human class 3 aldehyde dehydrogenases against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. J. Biol. Chem. 271 (1996) 11891-11896.
4. Bunting, K.D., Lindahl, R. and Townsend, A.J.: Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J. Biol. Chem. 269 (1994) 23197-23203.
5. Burgos, C., Gerez de Burgos, N.M., Rovai, L.E. and Blanco, A.: In vitro inhibition by gossypol of oxidoreductases from human tissues. Biochem. Pharmacol. 35 (1986) 801-804.
6. Chang, C.J.G., Ghosh, P.K., Hu, Y.F., Brueggemeier, R.W. and Lin, Y.C.: Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats. Res. Commun. Chem. Pathol. Pharmacol. 79 (1993) 293-312.
7. Chueh, S.-H., Chang, G.-G., Chang, T.-C. and Pan, F.: Involvement of arginine residue in the phosphate binding site of human placental alkaline phosphatase. Int. J. Biochem. 13 (1981) 1143-1149.
8. Coyle, T., Levante, S., Shetler, M. and Winfield, J.: In vilto and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines. J. Neurooncol. 19 (1994) 25-35.
9. Deck, L.M., Vander Jagt, D.L., Royer, R.E.: Gossypol and Derivatives: a new class of aldose reductase inhibitors. J. Med. Chem. 34 (1991) 3301-3305.
10. 4 activity of hamster spermatogenic epithelium in vitro. J. Reprod. Fertil. 83 (1988) 701-709.
11. Dockham, P.A., Lee, M.-O. and Sladek, N.E.: Identification of human aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem. Pharmacol. 43 (1992) 2453-2469.
12. FDA: Food drug cosmetic law. 56 (1974) 518.94, 172.894.
13. Feldman, R.I. and Weiner, H.: Horse liver aldehyde dehydrogenase. 11. Kinetics and mechanistic implications of the dehydrogenase and esterase activity. J. Biol. Chem. 247 (1972) 267-272.
14. Flack, M.R., Pyle, R.G., Mullen, N.M., Lorenzo, B., Wu, Y.W., Knazek, R.A., Nisula, B.C. and Reidenberg, M.M.: Oral gossypol in the treatment of metastatic adrenal cancer. J. Clin. Endocrinol. Metab. 76 (1993) 1019-1024.
15. Ford, J.M., Hait, W.N., Matlin, S.A. and Benz, C.C.: Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers. Cancer Lett. 56 (1991) 85-94.
16. Gilbert, N.E., O'Reilly, J.E., Chang, C.J.G., Lin, Y.C. and Brueggemeier, R.W.: Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci. 57 (1995) 61-67.
17. Hu, Y.-F., Chang, C.J.G., Brueggemeier, R.W. and Lin, Y.C.: Gossypol inhibits basal and estrogen-stimulated DNA synthesis in human breast carcinoma cells. Life Sci. 53 (1993) 433-438.
18. Hu, Y.-F., Chang, C.J.G., Brueggemeier, R.W. and Lin, Y.C.: Presence of antitumor activities in the milk collected from gossypol-treated dairy cows. Cancer Lett. 87 (1994) 17-23.
19. Ikeda, M.: Inhibition kinetics of NAD-linked enzymes by gossypol acetic acid. Andrologia 22 (1990) 409-416.
20. Joseph, A.E.A., Matlin, S.A. and Knox, P.: Cytotoxicity of enantiomers of gossypol. Br. J. Cancer 54 (1986) 511-513.
21. Kim, I.C., Waller, D.P. and Fong, H.H.S.: Inhibition of LDH-X by gossypol optical isomers. J. Androl. 6 (1985) 344-347.
22. Lambeir, A.-M., Loiseau, A.M., Kuntz, D.A., Vellieux, F.M., Michels, P.A.M. and Opperdoes, F.R.: The cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei. Kinetic properties and comparison with homologous enzymes. Eur. J. Biochem. 198 (1991) 429-435.
23. Lee, C.-Y.G., Moon, Y.S., Yuan, J.H., and Chen, A.F.: Enzyme inactivation and inhibition by gossypol. Mol. Cell. Biochem. 47 (1982) 65-70.
24. Messiha, F.S.: Effect of gossypol on kinetics of mouse liver alcohol and aldehyde dehydrogenase. Gen. Pharmacol. 22 (1991a) 573-576.
25. Messiha, F.S.: Behavioral and metabolic interaction between gossypol and ethanol. Toxicol. Lett. 57 (1991b) 175-181.
26. Moh, P.P., Chang, G.C.J., Brueggemeier, R.W. and Lin, Y.C.: Effect of gossypol on 5α-reductase and 3α-hydroxysteroid dehydrogenase activites in adult rat testes. Res. Comm. Chem. Pathol. Pharmacol. 82 (1993) 12-26.
27. Montamat, E. E., Burgos, C., Gerez de Burgos, N.M., Rovai, L.E. and Blanco, A.: Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi. Science 218 (1982) 288-289.
28. Moreb, J., Schweder, M., Suresh, A. and Zucali, J.R.: Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide. Cancer Gene Ther. 3 (1996) 24-30.
29. Morris, I.D., Higgins, C. and Matlin, S.A.: Inhibition of testicular LDH-X from laboratory animals and man by gossypol and its isomers. J. Reprod. Fertil. 77 (1986) 607-612.
30. Naik, H.R., Petrylak, D., Yagoda, A., Lehr, J.E., Akhtar, A. and Pienta, K.J.: Preclinical studies of gossypol in prostate carcinoma. Int. J. Oncol. 6 (1995) 209-213.
31. Nakadate, T., Jeng, A. Y. and Blumberg, P.M: Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action. Biochem. Pharmacol. 37 (1988) 1541-1545.
32. Olgiati, K.L. and Toscano, W.A. Jr.: Kinetics of gossypol inhibition of bovine lactate dehydrogenase X. Biochem. Biophys. Res. Commun. 115 (1983) 180-185.
33. Olgiati, K.L., Toscano, D.G., Atkins, W.M. and Toscano, W.A. Jr.: Gossypol inhibition of adenylate cyclase. Arch. Biochem. Biophys. 231 (1984) 411-415.
34. Rekha, G.K., Sreerama, L. and Sladek, N.E.: Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase. Biochem. Pharmacol. 48 (1994) 1943-1952.
35. Rosenberg, L.J., Adlakha, R.C., Desai, D.M. and Rao, P.N.: Inhibition of DNA polymerase α by gossypol. Biochim. Biophys. Acta 866 (1986) 258-267.
36. Royer, R.E., Mills, R.G., Deck, L.M., Mertz, G.J. and Vander Jagt, D.L.: Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol. Pharmcol. Res. 24 (1991) 407-412.
37. Sambrook, J., Fritsch, E.F. and Maniatis, T.: Preparation and transformation of competent E. coli. In Molecular Cloning. A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, 1989, pp. 1.74-1.84.
38. Sang, G. W., Lorenzo, B. and Reidenberg, M.M.: Inhibitory effects of gossypol on corticosteroid 11-β-hydroxysteroid dehydrogenase from guinea pig kidney: a possible mechanism for causing hypokalemia. J. Steroid Biochem. Mol. Biol. 39 (1991) 169-176.
39. Seidman, A.D.: Chemotherapy for advanced breast cancer: a current perspective. Semin. Oncol. 23 (1996) 55-59.
40. Sidhu, R.S. and Blair, A.H.: Human liver aldehyde dehydrogenase. Esterase activity. J. Biol. Chem. 250 (1975) 7894-7898.
41. Sladek, N.E.: Oxazaphosphorine-specific acquired cellular resistance. In Teicher, B.A. (Ed.), Drug Resistance in Oncology, Marcel Dekker, N.Y., 1993, pp. 375-411.
42. Sladek, N.E.: Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines. In Powis, G. (Ed.), Anticancer Drugs: Reactive Metabolism and Drug Interactions. Pergamon Press, United Kingdom, 1994, pp. 79-156.
43. Sladek, N.E., Sreerama, L. and Rekha, G.K.: Constitutive and overexpressed human cytosolic class-3 aldehyde dehydrogenases in normal and neoplastic cells/secretions. Adv. Exp. Med. Biol. 372 (1995) 103-114.
44. Sreerama, L. and Sladek, N.E.: Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Biochem. Pharmacol. 45 (1993a) 2487-2505.
45. Sreerama, L. and Sladek, N.E.: Overexpression or polycyclic aromatic hydrocarbon-mediated induction of an apparently novel class 3 aldehyde dehydrogenase in human breast adenocarcinoma cells and its relationship to oxazaphosphorine-specific acquired resistance. Adv. Exp. Med. Biol. 328 (1993b) 99-113.
46. Sreerama, L. and Sladek, N.E.: Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Cancer Res. 54 (1994) 2176-2185.
47. Sreerama, L. and Sladek, N.E.: Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide. Drug Metab. Dispos. 23 (1995) 1080-1084.
48. Sreerama, L., Rekha, G.K. and Sladek, N.E.: Phenolic antioxidant-induced Overexpression of class-3 aldehyde dehydrogenase and oxazaphosphorine-specific resistance. Biochem. Pharmacol. 49 (1995) 669-675.
49. Stein, R.C., Joseph, A.E.A., Matlin, S.A., Cunningham, D.C., Ford, H.T. and Coombes, R.C.: A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother. Pharmacol. 30 (1992) 480-482.
50. Tso, W.-W.: Gossypol inhibits Ehrlich ascites tumor cell proliferation. Cancer Lett. 24 (1984) 257-261.
51. Tuszynski, G.P. and Cossu, G.: Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines. Cancer Res. 44 (1984) 766-771.
52. Wichmann, K., Vaheri, A. and Luukkainen, T.: Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent. Am. J. Obstet. Gynecol. 142 (1982) 593-594.
53. Wilkinson, G.N.: Statistical estimations in enzyme kinetics. Biochem. J. 80 (1961) 324-332.
54. Wu, D.-F.: An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease. Drugs 38 (1989) 333-341.
55. -)-gossypol in humans and dogs. Clin. Pharmacol. Ther. 39 (1986) 613-618.
56. Wu, Y.-W., Chik, C.L. and Knazek, R.A.: An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma. Cancer Res. 49 (1989) 3754-3758.
57. -)-gossypol on the lactate dehydrogenase-X activity of rat testis. J. Ethnopharmacol. 20 (1987) 25-29.
58. -)-sterioisomers. J. Ethnopharmacol. 20 (1987) 65-78.
59. Zheng, C.-F., Wang, T.T.Y. and Weiner, H.: Cloning and expression of the full-length cDNAs encoding human liver class 1 and class 2 aldehyde dehydrogenase. Alcohol. Clin. Exp. Res. 17 (1993) 828-831.